Hosted by Unknown Host · 🇺🇸 US · EN-GB · 65 episodes
Established thought leaders with verified media credentials.
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Unknown Host hosts The Lancet HIV in conversation with, a health show with 65 episodes published.
Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance use—new research quantifies this burden, and we
Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than
People living with HIV often have many health needs beyond their antiretroviral medication. Editor in Chief Peter Hayward talks to Colette Smith of the Institute for Global Health at University College London about resul
Ageing with HIV brings new challenges. Even with effective ART, people ageing with HIV face increased risk of parkinsonism. Eran F Shorer from the Icahn School of Medicine at Mount Sinai joins us to explore the latest re
Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The La
Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for
In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a
Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new
Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into fact
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategie
In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Rea
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez
Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burne
Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and
Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding w
Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell a
Please note: this podcast is entirely in Spanish Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiz
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to en
Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV. Read this month´s anniversary editorial here: ht
Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission. Read the f
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch The Lancet HIV in conversation with, visit https://lancethiv.podbean.com for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent health coverage.
The Lancet HIV in conversation with is hosted by Unknown Host. The show is categorised under health (fitness) and has published 65 episodes.
The Lancet HIV in conversation with has published 65 episodes.
The Lancet HIV in conversation with regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
The Lancet HIV in conversation with is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The Lancet HIV in conversation with hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The Lancet HIV in conversation with average 24 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The Lancet HIV in conversation with's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 3 days ago.
